Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Immunotherapy of Primary Brain Tumors: Facts and Hopes.

Buerki RA, Chheda ZS, Okada H.

Clin Cancer Res. 2018 Nov 1;24(21):5198-5205. doi: 10.1158/1078-0432.CCR-17-2769. Epub 2018 Jun 5. Review.

PMID:
29871908
2.

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.

Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y, Okada H.

J Exp Med. 2018 Jan 2;215(1):141-157. doi: 10.1084/jem.20171046. Epub 2017 Dec 4.

3.

Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas.

Kohanbash G, Carrera DA, Shrivastav S, Ahn BJ, Jahan N, Mazor T, Chheda ZS, Downey KM, Watchmaker PB, Beppler C, Warta R, Amankulor NA, Herold-Mende C, Costello JF, Okada H.

J Clin Invest. 2017 Apr 3;127(4):1425-1437. doi: 10.1172/JCI90644. Epub 2017 Mar 20.

4.

Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors.

Chheda ZS, Sharma RK, Jala VR, Luster AD, Haribabu B.

J Immunol. 2016 Sep 1;197(5):2016-26. doi: 10.4049/jimmunol.1502376. Epub 2016 Jul 27.

5.

A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Sharma RK, Chheda ZS, Das Purkayastha BP, Gomez-Gutierrez JG, Jala VR, Haribabu B.

Clin Exp Metastasis. 2016 Mar;33(3):263-75. doi: 10.1007/s10585-015-9776-4. Epub 2015 Dec 15.

PMID:
26669782
6.

Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy.

Sharma RK, Chheda ZS, Jala VR, Haribabu B.

Expert Rev Vaccines. 2015 Apr;14(4):537-49. doi: 10.1586/14760584.2015.982101. Epub 2014 Dec 8. Review.

PMID:
25482400

Supplemental Content

Loading ...
Support Center